Lorin K. Johnson

1.6k total citations
30 papers, 1.3k citations indexed

About

Lorin K. Johnson is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Lorin K. Johnson has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Lorin K. Johnson's work include Inflammatory Bowel Disease (5 papers), Microscopic Colitis (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Lorin K. Johnson is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Microscopic Colitis (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Lorin K. Johnson collaborates with scholars based in United States, Australia and Canada. Lorin K. Johnson's co-authors include Miles K. Yamanaka, Jeffrey J. Seilhamer, Teri Randall, John Lewicki, John P. Longenecker, Ira Shafran, John D. Baxter, James L. Roberts, Beth S. Schachter and Judith Miller and has published in prestigious journals such as Nature, Cell and Gastroenterology.

In The Last Decade

Lorin K. Johnson

28 papers receiving 1.3k citations

Peers

Countries citing papers authored by Lorin K. Johnson

Since Specialization

Citations

This map shows the geographic impact of Lorin K. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorin K. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorin K. Johnson more than expected).

Fields of papers citing papers by Lorin K. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorin K. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorin K. Johnson. The network helps show where Lorin K. Johnson may publish in the future.

Co-authorship network of co-authors of Lorin K. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Lorin K. Johnson. A scholar is included among the top collaborators of Lorin K. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorin K. Johnson. Lorin K. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemoprevention of Colonic Polyps with Balsalazide: An Exploratory, Double-Blind, Placebo-Controlled Study 2009 ·Digestive Diseases and Sciences ·Jonathan P. Terdiman, Lorin K. Johnson, Young S. Kim, Marvin H. Sleisenger, James R. Gum, Ann Hayes, Vivian Weinberg, Kenneth R. McQuaid	8
2	An open-label evaluation of rifaximin in the treatment of active Crohn's disease 2005 ·Current Medical Research and Opinion ·Ira Shafran, Lorin K. Johnson	48
3	EFFICACY AND TOLERABILITY OF RIFAXIMIN, A NONABSORBED ORAL ANTIBIOTIC, IN THE TREATMENT OF ACTIVE CROHNʼS DISEASE: RESULTS OF AN OPEN-LABEL STUDY 2003 ·The American Journal of Gastroenterology ·Ira Shafran, Lorin K. Johnson, Lynne Hamm, Robert H. Murdock	2
4	Balsalazide Is Superior to Mesalamine in the Time to Improvement of Signs and Symptoms of Acute Mild-to-Moderate Ulcerative Colitis 2002 ·The American Journal of Gastroenterology ·Ronald E. Pruitt, John S. Hanson, Michael Safdi, Lawrence D. Wruble, Robert Hardi, John F. Johanson, (unknown), Dennis Riff, (unknown), Amanda J. Cross, Pamela Doty, Lorin K. Johnson	85
5	A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis1 2002 ·The American Journal of Gastroenterology ·Douglas S. Levine, Dennis Riff, Ronald E. Pruitt, Lawrence D. Wruble, (unknown), (unknown), (unknown), Lorin K. Johnson	105
6	Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute ulcerative colitis 2000 ·Gastroenterology ·Ronald E. Pruitt, John S. Hanson, Michael Safdi, Lawrence D. Wruble, Robert Hardi, John F. Johanson, (unknown), Dennis Riff, (unknown), Amanda J. Cross, Pamela Doty, Lorin K. Johnson	7
7	Structure of the Human Urokinase Receptor Gene and Its Similarity to CD59 and the Ly‐6 Family 1995 ·European Journal of Biochemistry ·Yao Wang, Jinjun Dang, Lorin K. Johnson, (unknown), William F. Doe	67
8	A strategy for obtaining active mammalian enzyme from a fusion protein expressed in bacteria using phospholipase A2 as a model 1991 ·Protein Expression and Purification ·Albert Tseng, Richard M. Buchta, Amanda E. Goodman, Marion Loughnan, (unknown), (unknown), Lorin K. Johnson, Adam S. Inglis, Kieran F. Scott	4
9	Localization and Evolution of Two Human Phospholipase A2 Genes and Two Related Genetic Elements 1990 ·Advances in experimental medicine and biology ·Lorin K. Johnson, (unknown), (unknown), W. Pruzanski, Aldons J. Lusis, Jeffrey J. Seilhamer	23
10	Multiple Forms of Phospholipase A2 in Arthritic Synovial Fluid 1989 ·The Journal of Biochemistry ·Jeffrey J. Seilhamer, (unknown), W. Pruzanski, J. S. Schilling, Eva Stefanski, Peter Vadas, Lorin K. Johnson	54
11	The primary structure of coho salmon growth hormone and its cDNA 1987 ·General and Comparative Endocrinology ·Charles S. Nicoll, (unknown), David S. King, Richard S. Nishioka, G Mayer, Norman L. Eberhardt, John D. Baxter, Miles K. Yamanaka, Judith Miller, Jeffrey J. Seilhamer, James W. Schilling, Lorin K. Johnson	50
12	Pancreatic Phospholipase A ₂ : Isolation of the Human Gene and cDNAs from Porcine Pancreas and Human Lung 1986 ·DNA ·Jeffrey J. Seilhamer, Teri Randall, Miles K. Yamanaka, Lorin K. Johnson	208
13	Distinct atrial natriuretic factor receptor sites on cultured bovine aortic smooth muscle and endothelial cells 1985 ·Biochemical and Biophysical Research Communications ·Dale B. Schenk, Lorin K. Johnson, Karen Schwartz, (unknown), Robert M. Scarborough, John Lewicki	123
14	Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor 1984 ·Nature ·Miles K. Yamanaka, Barry Greenberg, Lorin K. Johnson, (unknown), Michael Brewer, (unknown), Judith Miller, Steven A. Atlas, John H. Laragh, John Lewicki, John C. Fiddes	211
15	Synthesis of Growth Hormone, Prolactin, and Proopiomelanocortin by Intact Adult Ovine Pituitary Tissue in Vitro* 1982 ·Endocrinology ·Walter L. Miller, S Leisti, Lorin K. Johnson	21
16	Glucocorticoid influence on growth of vascular wall cells in culture 1982 ·Journal of Cellular Physiology ·John P. Longenecker, (unknown), Lorin K. Johnson	54
17	Synthesis and Glycosylation of Proopiomelanocortin by a Cushing Tumor* 1982 ·The Journal of Clinical Endocrinology & Metabolism ·Walter L. Miller, Lorin K. Johnson	14
18	Senescence of aortic endothelial cells in vitro: Influence of culture conditions and preliminary characterization of the senescent phenotype 1982 ·Mechanisms of Ageing and Development ·Lorin K. Johnson, John P. Longenecker	36
19	Altered adhesiveness of tumor cell surface variants with reduced metastasizing capacity – reduced adhesiveness to vascular wall components in culture 1982 ·International Journal of Cancer ·T. Tao, Lorin K. Johnson	28
20	Developmental transitions between chromatin-bound and soluble RNA polymerase subspecies in the soybean hypocotyl 1978 ·Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis ·Lorin K. Johnson, Bernard L. Strehler, Timothy J. O’Brien	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact